×
Phibro Animal Health EBIT 2012-2024 | PAHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Phibro Animal Health ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Phibro Animal Health EBIT 2012-2024 | PAHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Phibro Animal Health ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$202.6B
Stryker (SYK)
$144.4B
Boston Scientific (BSX)
$130.4B
Medtronic (MDT)
$113.2B
EssilorLuxottica (ESLOY)
$112.1B
Lonza Group Ag (LZAGY)
$45.3B
Haleon (HLN)
$43B
GE HealthCare Technologies (GEHC)
$39B
ResMed (RMD)
$36.5B
Terumo (TRUMY)
$30.6B
Koninklijke Philips (PHG)
$24.9B
Zimmer Biomet Holdings (ZBH)
$21.8B
Insulet (PODD)
$19.3B
Baxter (BAX)
$17.5B
Smith & Nephew SNATS (SNN)
$10.8B
Bio-Rad Laboratories (BIO)
$10.2B
BellRing Brands (BRBR)
$9.2B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$5.8B
TG Therapeutics (TGTX)
$4.8B
Haemonetics (HAE)
$4.6B
ICU Medical (ICUI)
$4.4B
Prestige Consumer Healthcare (PBH)
$4B
Perrigo (PRGO)
$3.6B
Envista Holdings (NVST)
$3.6B
Neogen (NEOG)
$3.6B
Agios Pharmaceuticals (AGIO)
$3.4B
GN Store Nord (GNNDY)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.9B